Phibro Animal Health Corporation - (PAHC): Price and Financial Metrics

Phibro Animal Health Corporation - (PAHC)

Today's Latest Price: $20.97 USD

0.34 (-1.60%)

Updated Jan 27 6:55pm

Add PAHC to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 78 in Medical - Services

See all "A" rated Strong Buy stocks

PAHC Stock Summary

  • Phibro Animal Health Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 89.41% of US listed stocks.
  • Phibro Animal Health Corp's stock had its IPO on April 11, 2014, making it an older stock than just 24.78% of US equities in our set.
  • Of note is the ratio of Phibro Animal Health Corp's sales and general administrative expense to its total operating expenses; 88.02% of US stocks have a lower such ratio.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Phibro Animal Health Corp are PRIM, ARC, CRI, KRO, and SGMA.
  • PAHC's SEC filings can be seen here. And to visit Phibro Animal Health Corp's official web site, go to

PAHC Stock Price Chart Interactive Chart >

Price chart for PAHC

PAHC Price/Volume Stats

Current price $20.97 52-week high $29.38
Prev. close $21.31 52-week low $16.27
Day low $20.60 Volume 131,700
Day high $21.72 Avg. volume 121,994
50-day MA $19.59 Dividend yield 2.29%
200-day MA $21.35 Market Cap 848.30M

Phibro Animal Health Corporation - (PAHC) Company Bio

Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company was founded in 2000 and is based in Teaneck, New Jersey.

PAHC Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$20.97$17.5 -17%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Phibro Animal Health Corp. To summarize, we found that Phibro Animal Health Corp ranked in the 47th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for PAHC, they are:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 68. Notably, its equity weight is greater than merely 19.73% of US equities in the Healthcare sector yielding a positive free cash flow.
  • Phibro Animal Health Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 7.47% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as PAHC, try FGEN, BDX, ADUS, AMED, and IQV.

PAHC Latest News Stream

Event/Time News Detail
Loading, please wait...

PAHC Latest Social Stream

Loading social stream, please wait...

View Full PAHC Social Stream

Latest PAHC News From Around the Web

Below are the latest news stories about Phibro Animal Health Corp that investors may wish to consider to help them evaluate PAHC as an investment opportunity.

Phirbo (PAHC) Nutritional Specialty Aids Growth, Low ASP Ails

Phirbo's (PAHC) net vaccine sales remain robust on higher international demand for poultry vaccines.

Yahoo | January 12, 2021

Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2020 Quarterly Financial Results

Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 3, 2021, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 4, 2021 at 9:00 AM Eastern Time.

Yahoo | January 5, 2021

TULISSIN® 100 Brand of Tulathromycin Now Approved by Health Canada

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health will represent and market Virbac’s newly approved TULISSIN® 100 brand of tulathromycin.

Business Wire | December 29, 2020

Veterinary Care Market for Asia and Latin America Worth USD 23 and USD 9 billion, by 2025 - Leading Companies are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France

According to the new market research report "Veterinary Care Market by Treatment Type (No medicalization, Basic Medicalization, and Under Long Term Veterinary Care), Animal Type (Dogs, Cats, Cattle, Horses, Pigs, and Poultry), and Region - Forecasts to 2025 ", published

OpenPR | December 16, 2020

Is PAHC A Good Stock To Buy Now?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and successful investors’ positions as of the end of the third quarter. You can find articles about an individual hedge fund’s trades on numerous financial […]

Yahoo | December 16, 2020

Read More 'PAHC' Stories Here

PAHC Price Returns

1-mo 9.79%
3-mo 28.38%
6-mo -8.50%
1-year -15.41%
3-year -36.78%
5-year -32.33%
YTD 7.98%
2020 -20.09%
2019 -21.31%
2018 -3.00%
2017 15.75%
2016 -1.16%

PAHC Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PAHC Dividend History

Continue Researching PAHC

Here are a few links from around the web to help you further your research on Phibro Animal Health Corp's stock as an investment opportunity:

Phibro Animal Health Corp (PAHC) Stock Price | Nasdaq
Phibro Animal Health Corp (PAHC) Stock Quote, History and News - Yahoo Finance
Phibro Animal Health Corp (PAHC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.1594 seconds.